SCPX: Scorpius Holdings, Inc. Stock

by  •  • Comments Off on SCPX: Scorpius Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.92
Enterprise Value ($M) 3.63
Book Value ($M) 28.29
Book Value / Share 0.79
Price / Book 0.24
NCAV ($M) -17.98
NCAV / Share -0.50
Price / NCAV -0.38

Profitability (mra)
Return on Invested Capital (ROIC) -1.07
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.75

Liquidity (mrq)
Quick Ratio 0.38
Current Ratio 0.47

Balance Sheet (mrq) ($M)
Current Assets 4.76
Assets 51.04
Liabilities 22.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.99
Operating Income -42.03
Net Income -45.22
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -31.53
Cash from Investing 32.24
Cash from Financing -8.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-12 13D/A Wolf Jeffrey Alan 13.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 93,664 343,825 27.24
2024-04-30 179,224 706,554 25.37
2024-04-29 2,065,159 8,533,425 24.20
2024-04-26 101,401 325,458 31.16

(click for more detail)

Similar Companies
PHGE – BiomX Inc. PLX – Protalix BioTherapeutics, Inc.
PTN – Palatin Technologies, Inc. TOVX – Theriva Biologics, Inc.
VCXB – 10X Capital Venture Acquisition Corp. III


Financial data and stock pages provided by
Fintel.io